# Prospective RCT Lidocaine & Levobupivacaine on Block Dynamics After Subparaneural Popliteal Sciatic Nerve Block

> **NCT04397484** · PHASE4 · RECRUITING · sponsor: **Chinese University of Hong Kong** · enrollment: 40 (estimated)

## Conditions studied

- Musculoskeletal Diseases or Conditions

## Interventions

- **DRUG:** 0.5% Levobupivacaine
- **DRUG:** 2% Xylocaine with adrenaline 1:200,000

## Key facts

- **NCT ID:** NCT04397484
- **Lead sponsor:** Chinese University of Hong Kong
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-09-20
- **Primary completion:** 2026-09-30
- **Final completion:** 2026-09-30
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2025-04-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04397484

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04397484, "Prospective RCT Lidocaine & Levobupivacaine on Block Dynamics After Subparaneural Popliteal Sciatic Nerve Block". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT04397484. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*